US Patent Issued to Akebia Therapeutics on July 7 for "Process for preparing [(3-hydroxypyridine-2-carbonyl)aminojalkanoic acids, esters and amides" (Canadian, American Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,919, issued on July 7, was assigned to Akebia Therapeutics Inc. (Cambridge, Mass.).

"Process for preparing [(3-hydroxypyridine-2-carbonyl)aminojalkanoic acids, esters and amides" was invented by Christopher M. Lanthier (Burlington, Canada), Boris Gorin (Oakville, Canada), Jan Oudenes (Aurora, Canada), Craig Edward Dixon (Brooklin, Canada), Alan Quigbo Lu (Mississauga, Canada), James Densmore Copp (Bargersville, Ind.) and John Michael Janusz (Oregonia, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are processes for preparing [(3-hydroxypyridine-2-carbonyl)amino]-alkanoic acids, derivatives, inter alia, 5-aryl substituted and 5-heteroar...